Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients

Jongha Park, Rajnish Mehrotra, Connie M. Rhee, Miklos Z. Molnar, Lilia R. Lukowsky, Sapna S. Patel, Allen R. Nissenson, Joel D. Kopple, Csaba Kovesdy, Kamyar Kalantar-Zadeh

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background. In hemodialysis patients, higher serum creatinine (Cr) concentration represents larger muscle mass and predicts greater survival. However, this association remains uncertain in peritoneal dialysis (PD) patients. Methods. In a cohort of 10 896 PD patients enrolled from 1 July 2001 to 30 June 2006, the association of baseline serum Cr level and change during the first 3 months after enrollment with all-cause mortality was examined. Results. The cohort mean ± SD age was 55 ± 15 years old and included 52% women, 24% African-Americans and 48% diabetics. Compared with patients with serum Cr levels of 8.0-9.9 mg/dL, patients with serum Cr levels of < 4.0 mg/dL and 4.0-5.9 mg/dL had higher risks of death {HR 1.36 [95% confidence interval (95% CI) 1.19-1.55] and 1.19 (1.08-1.31), respectively} whereas patients with serum Cr levels of 10.0-11.9 mg/dL, 12.0-13.9 mg/dL and ≥14.0 mg/dL had lower risks of death (HR 0.88 [95% CI 0.79- 0.97], 0.71 [0.62-0.81] and 0.64 [0.55-0.75], respectively) in the fully adjusted model. Decrease in serum Cr level over 1.0 mg/dL during the 3 months predicted an increased risk of death additionally. The serum Cr-mortality association was robust in patients with PD treatment duration of ≥12 months, but was not observed in those with PD duration of < 3 months. Conclusions. Muscle mass reflected in serum Cr level may be associated with survival even in PD patients. However, the serum Cr-mortality association is attenuated in the early period of PD treatment, suggesting competing effect of muscle mass versus residual renal function on mortality.

Original languageEnglish (US)
Pages (from-to)2146-2155
Number of pages10
JournalNephrology Dialysis Transplantation
Volume28
Issue number8
DOIs
StatePublished - Aug 1 2013

Fingerprint

Peritoneal Dialysis
Creatinine
Muscles
Mortality
Serum
Confidence Intervals
Survival
African Americans
Renal Dialysis
Kidney
Therapeutics

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Transplantation

Cite this

Park, J., Mehrotra, R., Rhee, C. M., Molnar, M. Z., Lukowsky, L. R., Patel, S. S., ... Kalantar-Zadeh, K. (2013). Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrology Dialysis Transplantation, 28(8), 2146-2155. https://doi.org/10.1093/ndt/gft213

Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. / Park, Jongha; Mehrotra, Rajnish; Rhee, Connie M.; Molnar, Miklos Z.; Lukowsky, Lilia R.; Patel, Sapna S.; Nissenson, Allen R.; Kopple, Joel D.; Kovesdy, Csaba; Kalantar-Zadeh, Kamyar.

In: Nephrology Dialysis Transplantation, Vol. 28, No. 8, 01.08.2013, p. 2146-2155.

Research output: Contribution to journalArticle

Park, J, Mehrotra, R, Rhee, CM, Molnar, MZ, Lukowsky, LR, Patel, SS, Nissenson, AR, Kopple, JD, Kovesdy, C & Kalantar-Zadeh, K 2013, 'Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients', Nephrology Dialysis Transplantation, vol. 28, no. 8, pp. 2146-2155. https://doi.org/10.1093/ndt/gft213
Park, Jongha ; Mehrotra, Rajnish ; Rhee, Connie M. ; Molnar, Miklos Z. ; Lukowsky, Lilia R. ; Patel, Sapna S. ; Nissenson, Allen R. ; Kopple, Joel D. ; Kovesdy, Csaba ; Kalantar-Zadeh, Kamyar. / Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. In: Nephrology Dialysis Transplantation. 2013 ; Vol. 28, No. 8. pp. 2146-2155.
@article{13282648824f4b179bcee24b689c0012,
title = "Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients",
abstract = "Background. In hemodialysis patients, higher serum creatinine (Cr) concentration represents larger muscle mass and predicts greater survival. However, this association remains uncertain in peritoneal dialysis (PD) patients. Methods. In a cohort of 10 896 PD patients enrolled from 1 July 2001 to 30 June 2006, the association of baseline serum Cr level and change during the first 3 months after enrollment with all-cause mortality was examined. Results. The cohort mean ± SD age was 55 ± 15 years old and included 52{\%} women, 24{\%} African-Americans and 48{\%} diabetics. Compared with patients with serum Cr levels of 8.0-9.9 mg/dL, patients with serum Cr levels of < 4.0 mg/dL and 4.0-5.9 mg/dL had higher risks of death {HR 1.36 [95{\%} confidence interval (95{\%} CI) 1.19-1.55] and 1.19 (1.08-1.31), respectively} whereas patients with serum Cr levels of 10.0-11.9 mg/dL, 12.0-13.9 mg/dL and ≥14.0 mg/dL had lower risks of death (HR 0.88 [95{\%} CI 0.79- 0.97], 0.71 [0.62-0.81] and 0.64 [0.55-0.75], respectively) in the fully adjusted model. Decrease in serum Cr level over 1.0 mg/dL during the 3 months predicted an increased risk of death additionally. The serum Cr-mortality association was robust in patients with PD treatment duration of ≥12 months, but was not observed in those with PD duration of < 3 months. Conclusions. Muscle mass reflected in serum Cr level may be associated with survival even in PD patients. However, the serum Cr-mortality association is attenuated in the early period of PD treatment, suggesting competing effect of muscle mass versus residual renal function on mortality.",
author = "Jongha Park and Rajnish Mehrotra and Rhee, {Connie M.} and Molnar, {Miklos Z.} and Lukowsky, {Lilia R.} and Patel, {Sapna S.} and Nissenson, {Allen R.} and Kopple, {Joel D.} and Csaba Kovesdy and Kamyar Kalantar-Zadeh",
year = "2013",
month = "8",
day = "1",
doi = "10.1093/ndt/gft213",
language = "English (US)",
volume = "28",
pages = "2146--2155",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients

AU - Park, Jongha

AU - Mehrotra, Rajnish

AU - Rhee, Connie M.

AU - Molnar, Miklos Z.

AU - Lukowsky, Lilia R.

AU - Patel, Sapna S.

AU - Nissenson, Allen R.

AU - Kopple, Joel D.

AU - Kovesdy, Csaba

AU - Kalantar-Zadeh, Kamyar

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Background. In hemodialysis patients, higher serum creatinine (Cr) concentration represents larger muscle mass and predicts greater survival. However, this association remains uncertain in peritoneal dialysis (PD) patients. Methods. In a cohort of 10 896 PD patients enrolled from 1 July 2001 to 30 June 2006, the association of baseline serum Cr level and change during the first 3 months after enrollment with all-cause mortality was examined. Results. The cohort mean ± SD age was 55 ± 15 years old and included 52% women, 24% African-Americans and 48% diabetics. Compared with patients with serum Cr levels of 8.0-9.9 mg/dL, patients with serum Cr levels of < 4.0 mg/dL and 4.0-5.9 mg/dL had higher risks of death {HR 1.36 [95% confidence interval (95% CI) 1.19-1.55] and 1.19 (1.08-1.31), respectively} whereas patients with serum Cr levels of 10.0-11.9 mg/dL, 12.0-13.9 mg/dL and ≥14.0 mg/dL had lower risks of death (HR 0.88 [95% CI 0.79- 0.97], 0.71 [0.62-0.81] and 0.64 [0.55-0.75], respectively) in the fully adjusted model. Decrease in serum Cr level over 1.0 mg/dL during the 3 months predicted an increased risk of death additionally. The serum Cr-mortality association was robust in patients with PD treatment duration of ≥12 months, but was not observed in those with PD duration of < 3 months. Conclusions. Muscle mass reflected in serum Cr level may be associated with survival even in PD patients. However, the serum Cr-mortality association is attenuated in the early period of PD treatment, suggesting competing effect of muscle mass versus residual renal function on mortality.

AB - Background. In hemodialysis patients, higher serum creatinine (Cr) concentration represents larger muscle mass and predicts greater survival. However, this association remains uncertain in peritoneal dialysis (PD) patients. Methods. In a cohort of 10 896 PD patients enrolled from 1 July 2001 to 30 June 2006, the association of baseline serum Cr level and change during the first 3 months after enrollment with all-cause mortality was examined. Results. The cohort mean ± SD age was 55 ± 15 years old and included 52% women, 24% African-Americans and 48% diabetics. Compared with patients with serum Cr levels of 8.0-9.9 mg/dL, patients with serum Cr levels of < 4.0 mg/dL and 4.0-5.9 mg/dL had higher risks of death {HR 1.36 [95% confidence interval (95% CI) 1.19-1.55] and 1.19 (1.08-1.31), respectively} whereas patients with serum Cr levels of 10.0-11.9 mg/dL, 12.0-13.9 mg/dL and ≥14.0 mg/dL had lower risks of death (HR 0.88 [95% CI 0.79- 0.97], 0.71 [0.62-0.81] and 0.64 [0.55-0.75], respectively) in the fully adjusted model. Decrease in serum Cr level over 1.0 mg/dL during the 3 months predicted an increased risk of death additionally. The serum Cr-mortality association was robust in patients with PD treatment duration of ≥12 months, but was not observed in those with PD duration of < 3 months. Conclusions. Muscle mass reflected in serum Cr level may be associated with survival even in PD patients. However, the serum Cr-mortality association is attenuated in the early period of PD treatment, suggesting competing effect of muscle mass versus residual renal function on mortality.

UR - http://www.scopus.com/inward/record.url?scp=84884565226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884565226&partnerID=8YFLogxK

U2 - 10.1093/ndt/gft213

DO - 10.1093/ndt/gft213

M3 - Article

VL - 28

SP - 2146

EP - 2155

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 8

ER -